[
    [
        {
            "time": "",
            "original_text": "高瓴资本三季度减仓：不确定性增加成新常态，安全边际与成长性需要重新定位",
            "features": {
                "keywords": [
                    "高瓴资本",
                    "减仓",
                    "不确定性",
                    "安全边际",
                    "成长性"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "全行业"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "高瓴资本三季度减仓：不确定性增加成新常态，安全边际与成长性需要重新定位",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "公募基金持股市值创新高，社保显著加仓周期股（附表）",
            "features": {
                "keywords": [
                    "公募基金",
                    "持股市值",
                    "创新高",
                    "社保",
                    "加仓",
                    "周期股"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "周期股"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "医药生物上市公司2021年三季报小结：板块业绩增速继续稳定 自下而上寻找专精特新",
            "features": {
                "keywords": [
                    "医药生物",
                    "三季报",
                    "业绩增速",
                    "稳定",
                    "专精特新"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物上市公司2021年三季报小结：板块业绩增速继续稳定 自下而上寻找专精特新",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 3
            }
        }
    ]
]